Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors.
about
Current status and perspectives of targeted therapy in well-differentiated neuroendocrine tumorsBevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapiesExpert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors.Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumorsPancreatic neuroendocrine tumors: approach to treatment with focus on sunitinibMode of action and clinical impact of VEGF signaling inhibitors.Liver-specific therapies for metastases of neuroendocrine pancreatic tumorsNovel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors.Pancreatic neuroendocrine and carcinoid tumors: what's new, what's old, and what's different?Translation of molecular pathways into clinical trials of neuroendocrine tumors.Angiogenesis in neuroendocrine tumors: therapeutic applications.Relevance of angiogenesis in neuroendocrine tumors.Sunitinib malate for the treatment of pancreas malignancies--where does it fit?Management of advanced and/or metastatic carcinoid tumors: historical perspectives and emerging therapies.Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations.Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors.Effects of T-type calcium channel blockers and thalidomide on contractions of rat vas deferens.Chemotherapy in NETs: When and how.
P2860
Q26823873-72CC20D7-D502-4BF8-A6E4-DAD170C9EB56Q31170918-B9C14B22-CE58-4B1F-9325-30243C912722Q33840177-2D516DE8-894D-4164-BAC6-C1E323A2D392Q34452319-236983F5-7AE1-4BC1-AB90-4D9317B97315Q36512778-ABDB3B7F-0529-4576-B444-8E8441E86715Q36790050-3AF38BCA-A193-4135-BB00-A0EEB16CFF18Q37130616-161FBB44-A0B1-4ECB-A677-89654076728EQ37483987-E01384FE-8F1C-4381-9FE2-897A23D96B18Q37821300-BB6B229D-1964-414E-A99C-B6A63ECD6022Q37936908-8985ECAA-8FB1-47F0-86C0-620BC448E917Q37995522-7C258BFD-3C3E-43BB-9D00-F2B118575E58Q38003074-E8F7C485-5A13-46B7-A027-E2AF682F756CQ38005887-BD551A45-6777-4DC9-9116-05A778A1103DQ38010658-B9375027-50C1-484A-BB72-DA7E1DED92B9Q38086310-4716359F-EA66-48A9-BD11-D317DBC23266Q38112804-3368F7B0-1A91-409A-9AFC-EA91D01CBA89Q38250467-5B13A863-EFDA-45D1-A33A-88A83785AF59Q38650864-BCE7A821-2C65-443E-A361-072C40822874Q39884279-DEDE53C0-8F96-4DE3-99AA-361982E9D1A9Q47692261-D250232D-DBAE-4D1B-841A-1D8DEE6F5192
P2860
Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Phase II study of thalidomide ...... rcinoid and islet cell tumors.
@ast
Phase II study of thalidomide ...... rcinoid and islet cell tumors.
@en
type
label
Phase II study of thalidomide ...... rcinoid and islet cell tumors.
@ast
Phase II study of thalidomide ...... rcinoid and islet cell tumors.
@en
prefLabel
Phase II study of thalidomide ...... rcinoid and islet cell tumors.
@ast
Phase II study of thalidomide ...... rcinoid and islet cell tumors.
@en
P2093
P1476
Phase II study of thalidomide ...... rcinoid and islet cell tumors.
@en
P2093
Jacqueline Campbell
Kimberly A Varker
Manisha H Shah
P2888
P304
P356
10.1007/S00280-007-0521-9
P577
2007-06-23T00:00:00Z
P5875
P6179
1026743485